New research and growing legal investigations are raising serious concerns about whether certain GLP-1 medications such as Ozempic, Wegovy, and Mounjaro may increase the risk of a rare but potentially devastating eye condition called Non-Arteritic Anterior Ischemic Optic Neuropathy, commonly known as NAION. 

NAION can cause sudden and often permanent vision loss. Many patients report waking up with blurred vision, blind spots, or darkened areas in one eye. Because these symptoms can develop quickly and without warning, patients are often left confused about what caused their vision loss and whether they may have legal options. 

If you were diagnosed with NAION after using Ozempic, Wegovy, Mounjaro, or another GLP-1 medication, you may qualify to file a lawsuit seeking compensation for your injuries. 

Contact the lawyers at Hissey Mulderig & Friend by calling our office toll-free at 1-866-806-8117, or send us a message using the contact form on the right side of this page. 

What Is NAION?

NAION is a condition that occurs when blood flow to the optic nerve becomes reduced or blocked. The optic nerve is responsible for transmitting visual signals from the eye to the brain. When the optic nerve does not receive enough blood supply, the nerve can become damaged, leading to vision loss. 

Unlike some other eye conditions, NAION typically develops suddenly. Many patients first notice symptoms when they wake up in the morning. In many cases, the vision loss caused by NAION is permanent and cannot be reversed. 

Research suggests that medications affecting blood flow, blood pressure, or vascular function may increase the risk of this condition. Investigators are now examining whether GLP-1 receptor agonist medications may contribute to optic nerve blood flow problems that lead to NAION. 

What Are GLP-1 Medications?

GLP-1 receptor agonists are prescription medications commonly used to treat Type 2 diabetes and, more recently, to assist with weight loss. Some of the most widely used GLP-1 medications include: 

• Ozempic 
• Wegovy 
• Mounjaro 
• Semaglutide based medications 
• Tirzepatide based medications 

These drugs work by helping regulate blood sugar levels, slowing digestion, and reducing appetite. While they have been widely prescribed and marketed as effective treatments, emerging reports suggest they may carry serious risks that were not fully disclosed to patients. 

Why Are Lawsuits Being Filed Over GLP-1 Vision Loss?

Studies have shown that Ozempic and other GLP-1 agonist medications are linked to an increased risk of sudden vision loss from NAION.

Patients and their families are filing lawsuits alleging that manufacturers of GLP-1 medications failed to adequately warn about the potential risk of NAION and sudden vision loss.  

Legal claims generally focus on allegations that drug manufacturers knew or should have known about these risks but did not provide sufficient warnings to doctors and patients. 

As additional medical studies and patient reports continue to emerge, litigation involving GLP-1 related vision injuries is expanding nationwide. 

Who May Qualify to File a NAION Lawsuit?

You may be eligible to file a lawsuit if you meet several key criteria. While every case is different, potential eligibility factors may include: 

Use of a GLP-1 Medication

You may qualify if you were prescribed and used Ozempic, Wegovy, Mounjaro, or another GLP-1 receptor agonist medication. 

Diagnosis of NAION or Sudden Vision Loss

To pursue a claim, you typically must have received a medical diagnosis of NAION or experienced unexplained optic nerve damage or sudden vision loss that doctors suspect is NAION. 

Vision Symptoms That Developed After Starting the Medication

Many potential cases involve patients who developed vision problems after beginning GLP-1 treatment. The timing between medication use and symptom development may be an important factor in evaluating eligibility. 

No Prior History of NAION 

Patients who developed NAION without a previous history of the condition may have stronger claims, particularly if symptoms appeared after beginning GLP-1 therapy. 

Impact on Your Life 

If NAION has affected your ability to work, drive, read, or maintain independence, these damages may be considered when evaluating your claim. 

What Compensation May Be Available?

Patients who qualify to file a lawsuit for GLP-1 related NAION may be able to seek compensation for a range of damages, including: 

• Medical expenses related to diagnosis and treatment 
• Vision rehabilitation and assistive devices 
• Lost income and reduced earning ability 
• Pain and suffering 
• Loss of quality of life 

Each case is unique, and the compensation available depends on the severity of the injury and its impact on the patient’s daily life. 

Why It Is Important to Act Quickly

There are strict legal deadlines that limit how long patients have to file a lawsuit after being diagnosed with NAION. Waiting too long could prevent you from pursuing compensation entirely. 

Additionally, early investigation allows attorneys to gather medical records, prescription history, and expert evaluations that may be critical to building a strong claim. 

How an Attorney Can Help Evaluate Your Case

Determining whether GLP-1 medication contributed to NAION can be medically and legally complex. An experienced mass tort attorney can help by: 

• Reviewing your medical and prescription history 
• Consulting medical experts regarding optic nerve injuries 
• Investigating manufacturer warnings and safety data 
• Determining whether you qualify to file a lawsuit 
• Pursuing compensation on your behalf 

Many patients are unsure whether their vision loss is connected to their medication. A case evaluation can help answer these questions and provide clarity about your legal rights. 

Speak With an Ozempic and GLP-1 Vision Loss Attorney Today

If you or a loved one developed NAION or experienced sudden vision loss after using Ozempic, Wegovy, Mounjaro, or another GLP-1 medication, you may be eligible to file a lawsuit and pursue compensation. 

The attorneys at Hissey Mulderig & Friend are actively investigating claims involving GLP-1 medications and optic nerve injuries. Our legal team has experience handling complex pharmaceutical injury cases and helping patients understand their legal options. 

We offer free and confidential case evaluations to help determine whether you may qualify for a claim. There are no fees unless we recover compensation for you. 

To learn more about your legal rights, contact Hissey Mulderig & Friend by calling toll-free at 1-866-806-8117, or by filling out our free claims submission form at the top of this page.